title: Heparin in stroke: not for most, but the controversy lingers.
authors.affiliation: National Stroke Research Institute, Austin and Repatriation Medical Center and the University of Melbourne, Australia. donnan@austin.unimelb.edu.au
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Donnan
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Davis
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D020521:Stroke / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D006493:Heparin